Marc Vitorillo

Marc Vitorillo is a leading expert in semaglutide weight loss and telehealth, with 17 years of experience in the healthcare and wellness field. Passionate about making healthcare more accessible, Marc collaborates with licensed providers and telehealth services to ensure patients receive comprehensive, remote care tailored to their unique needs. Through Hugsy.com, Marc shares the latest research, success stories, and expert guidance on semaglutide for weight loss, empowering individuals to achieve their health goals safely and effectively. Whether you're considering semaglutide or looking for reliable telehealth options, Marc is your go-to resource for expert advice and compassionate care.

Lose Weight Effectively with Semaglutide – Proven Medical Weight Loss Solution

At Hugsy, our mission is to provide you with innovative, safe, and effective medical weight loss solutions tailored to your unique needs. One of the most promising treatments available today is Semaglutide —a breakthrough medication designed to aid in weight loss by targeting specific hormones in the body. As a telehealth-based provider, Hugsy brings the […]

Lose Weight Effectively with Semaglutide – Proven Medical Weight Loss Solution Read More »

John Brenkus: The Science of The Super Patch

John Brenkus: The Science of The Super Patch

John Brenkus is a co-founder of BASE Productions, he co-created the groundbreaking series Fight Science for the National Geographic Channel and serves as the on-air host, co-creator, and executive producer of ESPN’s six-time Emmy Award-winning show Sport Science. The future of wellness in a Patch. Wellness and performance mean different things to different people. At

John Brenkus: The Science of The Super Patch Read More »

Sublingual Semaglutide

A Needle-Free Approach to Effective Weight Loss In the ever-evolving landscape of medical advancements, a groundbreaking solution has emerged for individuals seeking effective weight loss strategies without the fear of needles. Sublingual Semaglutide, a revolutionary medication, offers an innovative approach to weight management. Designed for those who prefer a non-invasive method, this anhydrous liquid-based product

Sublingual Semaglutide Read More »

mounjaro vs wegovy

Mounjaro vs Wegovy

Pharmaceutical giant, Lilly, has launched a clinical trial that will compare the efficacy of their newly released drug, Mounjaro, with Novo Nordisk’s Wegovy in treating obesity. This head-to-head trial will evaluate the weight loss achieved by patients who take either Mounjaro or Wegovy over a period of 52 weeks. The trial will involve around 1,200

Mounjaro vs Wegovy Read More »